Ep. 44 - Biotech's IPO blizzard, plus GameStop, Porter Report & Vaccine Guidance
Reach us by sending a text
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.
For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.